Chronic migraine is one of the most debilitating neurological conditions in the world, affecting an estimated 148 million people globally and defined by the experience of 15 or more headache days per month, with at least 8 of those days meeting criteria for migraine. For the millions living with this condition, chronic migraine is not merely a recurrent headache — it is a condition that disrupts employment, relationships, cognitive function, and quality of life on a scale placing it among the top causes of years lived with disability worldwide. The treatment landscape for chronic migraine has been transformed in recent years by the approval of CGRP (calcitonin gene-related peptide) monoclonal antibodies — erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), and eptinezumab (Vyepti) — representing the first class of preventive medications designed specifically for migraine rather than repurposed from other indications. The digital health platforms underpinning this new era of migraine care — digital headache diary apps, CGRP injection tracking portals, trigger pattern analysis platforms integrating wearable sensor data, rescue medication overuse detection systems, and infusion center scheduling platforms for eptinezumab — are the infrastructure through which neurologists and headache specialists monitor treatment response and intervene before medication overuse converts episodic migraine to chronic.
When a headache diary platform fails during the 30-day tracking period before a quarterly CGRP dosing appointment and the neurologist arrives at the visit without longitudinal headache frequency data, the clinical assessment depends on unreliable patient recall rather than the objective diary data that determines whether the current preventive is working. When a rescue medication overuse detection system stops logging triptan administrations and fails to generate an alert for a patient who has crossed the threshold into medication overuse headache (MOH), the clinical team loses the signal that would trigger a preventive protocol change before the patient becomes dependent on the rescue medication causing the problem. When an infusion center scheduling platform fails and a patient cannot book their quarterly eptinezumab infusion within the scheduling window, their next CGRP dose is delayed and their migraine frequency may increase.
This guide explains what chronic migraine care technology platforms must have monitored, why uptime directly affects preventive treatment efficacy and medication overuse outcomes for this population, and how to build a monitoring configuration calibrated to the quarterly treatment rhythms and wearable integration demands of modern migraine care.
Why Chronic Migraine Care Tech Platforms Require Specialized Monitoring Attention
Chronic migraine care platforms coordinate across CGRP preventive therapy monitoring, digital headache diary collection, trigger pattern analysis, rescue medication overuse surveillance, and infusion center scheduling — each domain with its own availability stakes and clinical timing dependencies.
Digital headache diary apps are the primary clinical outcome measurement tool for CGRP therapy assessment. The clinical decision whether to continue, switch, or escalate CGRP preventive therapy is based on the change in headache frequency from baseline to treatment — a calculation that requires accurate longitudinal headache diary data. Leading digital diary platforms — Migraine Buddy integration, clinical diary apps embedded in CGRP therapy management portals, neurologist-prescribed tracking apps — collect daily migraine onset, duration, severity, associated symptoms, and medication use. A platform failure during the critical tracking month before a quarterly CGRP appointment creates a gap that cannot be backfilled from memory. Monitor headache diary submission API, daily entry processing, trend computation, and neurologist dashboard data at 2-minute intervals, 24/7. Alert after 5 minutes of sustained failure during peak diary entry windows (morning and evening hours when patients most frequently log attacks).
CGRP injection tracking portals manage self-injection adherence and adverse event surveillance. Subcutaneous CGRP monoclonal antibodies — erenumab and galcanezumab as monthly self-injections, fremanezumab as monthly or quarterly — are self-administered by patients at home. Digital platforms that track injection date and time, injection site rotation, post-injection side effect reports (injection site reactions, constipation, hypertension), and send injection-due reminders are the pharmacovigilance and adherence infrastructure for a medication class where consistent monthly adherence is required to achieve sustained migraine frequency reduction. A failure in the injection tracking API means a missed injection that is not caught by the reminder system — and a month without CGRP coverage in a patient whose migraine control depends on consistent serum drug levels. Monitor injection log submission, injection-due reminder dispatch, side effect report processing, and adherence trend computation at 2-minute intervals, 24/7. Alert after 5 minutes of sustained failure.
Trigger pattern analysis platforms integrate wearable sensor data with diary data to identify migraine precipitants. Advanced chronic migraine management platforms integrate meteorological data, sleep quality signals from wearables, heart rate variability, menstrual cycle tracking, dietary intake logs, and physical activity data to identify the trigger patterns that precede individual migraine attacks. This multi-modal data integration is the computational layer that converts a generic migraine diary into a personalized trigger profile — enabling patients and clinicians to reduce preventable attack burden. A silent failure in the wearable data ingestion pipeline or the trigger correlation computation service creates gaps in the most clinically actionable data the platform produces. Monitor wearable API authentication, sleep and HRV data ingestion, environmental data integration, trigger correlation computation, and personalized insight delivery at 3-minute intervals, 24/7. Alert after 20 minutes of sustained failure.
Rescue medication overuse detection systems prevent medication overuse headache (MOH). Medication overuse headache — the paradoxical worsening of chronic migraine through excessive use of acute rescue medications — is one of the most common and treatment-refractory complications of chronic migraine management. Platforms that track triptan administration frequency, OTC analgesic use logs, and NSAID use against clinically established MOH thresholds (triptans: 10+ days/month; simple analgesics: 15+ days/month) and alert prescribers when a patient is approaching or has crossed into medication overuse territory are the primary clinical safeguard against this iatrogenic complication. A failure in the medication use tracking API or the MOH alert generation service creates a window during which patients can cross into medication overuse without clinical detection. Monitor medication use log submission, MOH threshold evaluation, prescriber alert generation, and patient notification dispatch at 2-minute intervals, 24/7. Alert immediately on MOH alert generation failures.
Infusion center scheduling platforms coordinate quarterly eptinezumab administration. Eptinezumab (Vyepti) is administered as a quarterly intravenous infusion at an infusion center — a scheduling and logistics workflow that differs fundamentally from subcutaneous self-injection. Platforms that manage infusion center appointment scheduling, insurance prior authorization tracking, and infusion nurse communication must be available when patients attempt to book their quarterly infusion within the scheduling window before their current dose's efficacy begins to wane. A scheduling portal failure during the booking window means patients call infusion centers directly, bypass the platform's prior authorization tracking, and create administrative gaps that can delay coverage. Monitor the infusion center scheduling API, appointment availability query, prior authorization status tracking, and patient notification dispatch at 2-minute intervals during business hours.
Neuromodulation device integration portals support non-pharmacological preventive therapy. FDA-cleared neuromodulation devices — Cefaly (supraorbital neurostimulation), gammaCore (vagal nerve stimulation), and Nerivio (remote electrical neurostimulation) — generate session logs and compliance data that neurologists use to assess non-pharmacological treatment adherence. A failure in the device data sync API leaves neurologists without compliance data for patients using neuromodulation as a standalone or adjunctive preventive. Monitor device data sync API, session log ingestion, and compliance reporting at 3-minute intervals during clinic hours.
What to Monitor on a Chronic Migraine Care Tech Platform
Headache Diary: Submission API and Trend Computation
Monitor the diary entry submission endpoint, attack attribute logging (onset, duration, severity, symptoms), medication use capture, trend computation service, and neurologist dashboard display. Check at 2-minute intervals, 24/7. Alert after 5 minutes of sustained failure during peak entry windows (morning 7–10am and evening 7–10pm).
CGRP Injection Tracking and Reminder Dispatch
Monitor injection log submission, injection-due reminder generation and dispatch, side effect report API, adherence trend computation, and prescriber alert generation for missed injections. Check at 2-minute intervals, 24/7. Alert after 5 minutes of sustained failure.
Rescue Medication Overuse Detection and MOH Alerting
Monitor medication use log submission, rescue medication frequency computation, MOH threshold evaluation, prescriber alert generation, and patient notification dispatch. Check at 2-minute intervals, 24/7. Alert immediately on MOH alert generation failures.
Trigger Pattern Analysis: Wearable Data Pipeline
Monitor wearable device API authentication, sleep quality and HRV data ingestion, environmental data integration, dietary and activity log processing, trigger correlation computation, and personalized insight delivery. Check at 3-minute intervals, 24/7. Alert after 20 minutes of sustained failure.
Infusion Center Scheduling and Prior Authorization
Monitor the infusion scheduling API, appointment availability query, prior authorization status tracking, insurance verification endpoint, and patient appointment confirmation dispatch. Check at 2-minute intervals during business hours. Alert after 10 minutes of sustained failure during the scheduling window before quarterly infusion dates.
Neuromodulation Device Data Sync
Monitor device data sync API, session log ingestion, compliance data aggregation, and clinician dashboard display. Check at 3-minute intervals during clinic hours. Alert after 15 minutes of sustained failure.
Preventive Medication Response Tracking
Monitor preventive medication adherence logging (topiramate, propranolol, amitriptyline, valproate), response trend computation, and CGRP therapy response score generation. Check at 2-minute intervals, 24/7. Alert after 10 minutes of sustained failure.
EHR Integration and Neurology Record Access
Monitor HL7/FHIR integration endpoints pulling prior neurological evaluation, medication history, and imaging records, and writing headache diary summary and treatment response notes to the EHR. Alert after 10 minutes of sustained integration failure.
Authentication Across All User Roles
Monitor authentication for neurologists, headache specialists, nurses, infusion center staff, pharmacists, and patient-facing app users. Check at 1-minute intervals, 24/7. Authentication failures lock all concurrent clinical users and patients out simultaneously.
SSL Certificates Across All Domains
Monitor SSL certificate expiry across clinical portal, patient diary app, infusion scheduling platform, and wearable integration API domains. A certificate expiry on the patient diary domain blocks diary entry for the entire patient population.
HIPAA and Chronic Migraine Data Privacy Considerations
Chronic migraine care platforms handle neurological diagnoses, detailed pain history and attack logs, prescription medication records (including controlled substances when opioids or barbiturates are prescribed for rescue), wearable biometric data including sleep and HRV, and behavioral patterns through food, sleep, and activity tracking. While migraine is not as highly stigmatized as psychiatric diagnoses, the combination of detailed behavioral tracking data and neurological diagnosis creates a rich PHI profile that warrants careful data governance.
CGRP monoclonal antibody records present particular privacy sensitivity in the context of prior authorization and insurance appeals. Patient-reported headache frequency data submitted through digital platforms may be used in insurance prior authorization appeals for expensive CGRP medications (annual cost: $7,000–$9,000); platforms must have audit trails for the data used in insurance submissions and ensure that PHI disclosed to payers meets the minimum necessary standard.
Wearable integration data — sleep quality, HRV, activity, and GPS-based environmental exposure — collected from consumer devices and integrated into migraine trigger analysis platforms occupies a regulatory space that may not be fully covered by the treating provider's HIPAA BAA with the wearable device manufacturer. Platforms should document the data governance boundaries for each wearable data source and ensure patient consent covers the analytical use of consumer-device biometric data.
Uptime monitoring records demonstrate to health system clients, headache specialty practice managers, and compliance reviewers that the platform maintains HIPAA Security Rule technical safeguards for PHI availability, including for the diary and medication data used in insurance prior authorization submissions.
Alerting Strategy for Chronic Migraine Care Tech Platforms
Immediate 24/7 alert: Authentication across all users, MOH alert generation service. Authentication failures lock all clinical and patient users; a failed MOH alert is a missed iatrogenic complication signal.
Sustained-failure alert (5 minutes): Headache diary submission during peak diary entry windows; CGRP injection tracking and reminder dispatch; rescue medication use log submission.
Sustained-failure alert (10 minutes): Infusion center scheduling during active scheduling windows; preventive medication response tracking; EHR integration endpoints.
Sustained-failure alert (15–20 minutes): Trigger pattern analysis wearable data pipeline; neuromodulation device data sync; environmental data integration.
30-day advance warning: SSL certificates across all clinical, patient-facing, and wearable integration domains.
Vigilmon's multi-region monitoring verifies that chronic migraine platform endpoints are reachable from the network regions where patients are logging diary entries during acute migraine attacks, self-administering CGRP injections at home, and accessing trigger pattern insights on mobile devices — critical for consumer-facing platforms with a geographically dispersed user base.
Status Page for Neurologist, Patient, and Infusion Center Communication
A real-time status page gives neurologists, headache specialists, infusion center nurses, and patients immediate confirmation when a platform outage — a diary app that won't accept an entry during an acute attack, an infusion scheduling portal that returns errors during the quarterly booking window, a CGRP injection reminder that never arrives — is a confirmed platform incident rather than a local connectivity or device issue.
For patients managing chronic migraine, who may be experiencing severe head pain, photophobia, and phonophobia when they most need the platform to function, portal downtime is not merely inconvenient — it is a failure during the moments of highest need. Include the status page URL in patient onboarding materials and ensure alternative diary logging instructions (paper backup, email reporting) and direct infusion center contact information are visible on the status page.
Vigilmon Setup for Chronic Migraine Care Tech Platforms
A practical starting configuration:
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Authentication / all user roles | 1 min | PagerDuty (24/7, immediate) | | MOH alert generation service | 2 min | PagerDuty (24/7, immediate) | | Headache diary submission API | 2 min | Slack (sustained 5 min, peak diary hours) | | CGRP injection tracking and reminder dispatch | 2 min | Slack (sustained 5 min, 24/7) | | Rescue medication use log and MOH threshold | 2 min | Slack + PagerDuty (sustained 5 min, 24/7) | | Infusion center scheduling API | 2 min | Slack (sustained 10 min, business hours) | | Trigger pattern analysis wearable pipeline | 3 min | Slack (sustained 20 min, 24/7) | | Neuromodulation device data sync | 3 min | Slack (sustained 15 min, clinic hours) | | Preventive medication response tracking | 2 min | Slack (sustained 10 min, 24/7) | | EHR integration / FHIR endpoints | 5 min | Slack (sustained 10 min) | | SSL: all clinical and patient-facing domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add authentication and MOH alert generation as highest-priority monitors with immediate 24/7 PagerDuty alerting
- Add headache diary submission with 2-minute intervals and 5-minute sustained-failure alerting during morning and evening peak diary hours
- Configure CGRP injection tracking and rescue medication use log monitors with 5-minute sustained-failure alerting
- Add infusion center scheduling monitors with 10-minute sustained-failure alerting during business hours
- Configure trigger pattern analysis wearable data pipeline with 20-minute sustained-failure alerting
- Add neuromodulation device data sync and preventive medication response tracking monitors
- Configure EHR integration monitors with 10-minute sustained-failure alerting
- Enable SSL certificate monitoring across all clinical, patient-facing, and wearable integration domains
- Publish the status page URL in patient onboarding materials with paper diary backup instructions and direct infusion center contact information visible independently of any platform-dependent channel
Conclusion
Chronic migraine care technology platforms coordinate across a uniquely patient-centric and time-sensitive clinical workflow — quarterly CGRP therapy response assessment based on headache diary data that must be collected without gaps over the full treatment period, CGRP self-injection adherence tracking with monthly dosing windows where a missed reminder means a missed dose, rescue medication overuse detection that must catch MOH before the patient becomes dependent on the medication causing the problem, trigger pattern analysis integrating wearable and environmental data to identify individualized attack precipitants, and infusion center scheduling that must be available when quarterly eptinezumab booking windows open. When these platforms fail silently, the consequences accumulate invisibly — a neurologist assessing CGRP response without complete diary data, a patient who crossed into medication overuse headache without a prescriber alert, an infusion booking missed because the scheduling portal was down.
Uptime monitoring gives chronic migraine care tech teams the detection capability to identify failures within seconds, respond before diary collection windows close or medication overuse thresholds are crossed without clinical detection, and demonstrate to health systems, headache specialty practices, and compliance reviewers that the platform's availability is built for the continuous monitoring demands of a condition that affects patients on 15 or more days every month.
Start monitoring your chronic migraine care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and webhook alerts. No agent required. No credit card.
Tags: #monitoring #chronicmigraine #migraine #cgrp #erenumab #fremanezumab #headachediary #migrainebuddy #medicationoveruse #neuromodulation #digitalhealth #uptime #hipaa #neurology #sre